InvestorsHub Logo

Rubyred77

11/04/17 5:17 PM

#128478 RE: kld2 #128476

For the 100th time, financing is good even WITH trials starting per Missling. If you don't believe it or doubt it, then why invest in a ticker that you have no trust in the CEO to execute his job.

XenaLives

11/04/17 5:34 PM

#128501 RE: kld2 #128476

You do not read the board sentiment correctly...

plexrec

11/04/17 5:47 PM

#128512 RE: kld2 #128476

kid..."if i read the board sentiment correctly"---you must be reading some other board--this one is much overweight bullish--check again !!!!!

frrol

11/04/17 7:46 PM

#128552 RE: kld2 #128476

I find the 6 sustained patients encouraging. If the company is representing the concentration and disease severity dependencies accurately (no correlation data on the 6, so I can't attest) then it's a glimmer of potential efficacy and important future trial design.